Insta
Covid-19 vaccine - representative image (Twitter)
In a major development for the vaccination drives ongoing in various nations across the world, Finland's medical agency has received the first report of an adverse reaction to the COVID-19 vaccine developed by the United States (US) based pharmaceutical major Pfizer and German BioNTech, reports Livemint.
This comes just a week after Europe began its mass immunisation drive on 27 December following the authorisation provided by the European Commission. However, no information has been revealed about the nature of the adverse reaction reported.
Kaukonen refused to share any further details citing patient confidentiality.
Pfizer and BioNTech's vaccine has also applied for an emergency use authorisation in India. It had placed its papers before the authorities in December. Meanwhile, the authorities have accorded the emergency use authorisation to the Covaxin and Covishield vaccines in India.